Cytokinetics (CYTK) PT Raised to $22 at Piper Sandler
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $75.87 +2.35%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff raised the price target on Cytokinetics (NASDAQ: CYTK) to $22.00 (from $20.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Citi Downgrades Northern Star Resources (NST:AU) (NESRF) to Neutral
- Adani Ports & Special Economic Zone (ADSEZ:IN) PT Raised to INR1,973 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Edward TenthoffSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
